ArticleRSC advances2023
Multicomponent oxide microspheres with designed macroporosity (MICROSCAFS®): a customized platform for chemicals immobilization.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
- Robust Photocatalytic MICROSCAFSInternational journal of molecular sciences · 2024Article
- Mechanistic Study of the Formation of Multicomponent Oxide Porous Microspheres (MICROSCAFSGels (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel versatile, easily recoverable, and recyclable material platform is herein presented, consisting of multicomponent oxide microspheres, of silica-titania and silica-titania-hafnia composition, with tailored interconnected macroporosity (MICROSCAFS®). When functionalized or loaded with desired species, they are potential enablers of emerging applications in environmental remediation, among other fields. We combine emulsion templating for the spherical shape of the particles, with an adapted sol-gel technique involving polymerization-induced phase separation by spinodal decomposition. An advantage of our method regards the employed mix of precursors, which prevents the use of specific gelation additives and porogens and allows a high reproducibility of MICROSCAFS®. We present insight into their formation mechanism using cryo-scanning electron microscopy, and a systematic study of the effect of multiple synthesis parameters on the MICROSCAFS® size and porosity. The composition of the silicon precursors has the most significant effect on fine-tuning the pores size, ranging from the nanometer to the micron scale. Mechanical properties are correlated with morphological features. Larger macroporosity (68% open porosity, estimated by X-ray computed tomography) leads to less stiffness, higher elastic recovery, and compressibility values up to 42%. We believe this study creates a base for consistent custom MICROSCAFS® production, with a design for various future applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.